Opportunity Information: Apply for CDC RFA GH11 1109SUPP16
Apply for CDC RFA GH11 1109SUPP16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Strengthening Local Capacity to Provide Sustainable HIV-Related Care and Treatment Services in South Africa under PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Jan 08, 2016 and posted on Jan 08, 2016.
- Applicants must submit their applications by Mar 08, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Strengthening Local Capacity to Provide Sustainable HIV-Related Care and Treatment Services in South Africa under PEPFAR" (Funding Opportunity Number: CDC RFA GH11 1109SUPP16), is a U.S. Centers for Disease Control and Prevention (HHS-CDC) cooperative agreement intended to support implementation of the DREAMS initiative in South Africa. The award is positioned as a discretionary funding opportunity under CFDA 93.067, with an expected single award. While the listing shows an award ceiling of 0 (often meaning the amount is not specified in the public summary), it is clearly designed to resource a selected implementer to carry out DREAMS-aligned programming.
The opportunity is framed around DREAMS, which stands for Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe. DREAMS was launched in 2015 as a major partnership involving PEPFAR alongside the Bill and Melinda Gates Foundation and the Nike Foundation, backed by a reported $210 million commitment. The core purpose is to reduce new HIV infections among adolescent girls and young women across ten sub-Saharan African countries, including South Africa. Rather than relying only on clinic-based services, DREAMS emphasizes a layered, evidence-based package that reaches beyond the health sector to confront the structural and social conditions that raise HIV vulnerability for girls and young women.
A central theme of the announcement is that HIV risk for adolescent girls and young women is heavily shaped by factors such as poverty, gender inequality, sexual violence, and barriers to education. Because of that, DREAMS programming is expected to combine biomedical, behavioral, and structural interventions, linking health services with community and social supports. The intent is not only to address immediate prevention needs, but also to build local capacity and sustainability so that services and protective factors remain in place over time.
Geographically, the DREAMS work supported by this announcement focuses on five priority districts in South Africa: eThekwini, uMgungundlovu, and uMkhanyakude in KwaZulu-Natal, and the City of Johannesburg and Ekurhuleni in Gauteng. Across these five districts there are 31 sub-districts, with DREAMS concentrating efforts in 19 sub-districts identified as high burden and high transmission areas. This targeting signals that applicants are expected to plan for intensive, localized implementation where incidence and transmission dynamics are most acute.
Programmatically, the opportunity highlights four main DREAMS objectives: empowering girls and young women, mobilizing communities, strengthening families, and providing social protection. In practical terms, this means supporting interventions that increase girls agency and resilience, shift harmful community norms, improve family support systems, and connect beneficiaries to services that reduce economic and social vulnerability. The announcement also links these objectives to concrete life outcomes, including improved school enrollment, attendance, and completion at the secondary level, as well as reductions in violence and unintended pregnancy, all of which are understood to influence HIV risk and long-term wellbeing.
The funding opportunity sets ambitious prevention targets for the primary population of interest: adolescent girls and young women ages 15-24. Specifically, it states that the FOA supports DREAMS goals to reduce new HIV infections in this age group by 25 percent by the end of 2016 and by 40 percent by the end of 2017. These targets imply a strong focus on measurable impact, rapid scale-up in priority sub-districts, and coordinated delivery of multiple interventions rather than isolated activities.
Eligibility in the narrative references Health Systems Trust, and the formal eligibility field is listed as "Others" with additional clarification implied elsewhere in the original notice. The key takeaway is that CDC is seeking an eligible organization capable of coordinating and implementing a multi-sectoral, evidence-driven package under a cooperative agreement structure, meaning CDC would likely have substantial involvement through technical guidance and collaboration during implementation. The application closing date listed is March 8, 2016, and the opportunity was posted January 8, 2016, indicating this was a time-bound call aligned to early DREAMS rollout timelines.
Frequently Asked Questions (FAQs)
1) What is the name of this funding opportunity?
The opportunity is titled "Strengthening Local Capacity to Provide Sustainable HIV-Related Care and Treatment Services in South Africa under PEPFAR."
2) What is the Funding Opportunity Number (FON) for this announcement?
The Funding Opportunity Number is CDC RFA GH11 1109SUPP16.
3) Which U.S. agency is offering this grant?
This is a U.S. Centers for Disease Control and Prevention (HHS-CDC) cooperative agreement opportunity.
4) What type of funding mechanism is this?
The announcement describes the award as a cooperative agreement, which typically means the CDC is expected to have substantial involvement through collaboration and technical guidance during implementation (as indicated in the opportunity summary).
5) Under what CFDA number is this opportunity listed?
It is listed under CFDA 93.067.
6) Is this a discretionary funding opportunity?
Yes. The opportunity is positioned as a discretionary funding opportunity.
7) How many awards are expected?
The summary indicates an expected single award.
8) What is the award amount or ceiling?
The public listing shows an award ceiling of 0, which often indicates the amount is not specified in the public summary. The description still indicates the intent is to resource one selected implementer to carry out DREAMS-aligned programming.
9) What initiative is this funding meant to support?
This opportunity is intended to support implementation of the DREAMS initiative in South Africa under PEPFAR.
10) What does DREAMS stand for?
DREAMS stands for Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe.
11) When was DREAMS launched, and who is involved?
DREAMS was launched in 2015 as a partnership involving PEPFAR alongside the Bill and Melinda Gates Foundation and the Nike Foundation, backed by a reported $210 million commitment.
12) What is the overall purpose of DREAMS?
The core purpose is to reduce new HIV infections among adolescent girls and young women across ten sub-Saharan African countries, including South Africa.
13) Who is the primary population of interest?
The primary population of interest is adolescent girls and young women ages 15-24.
14) Why does DREAMS go beyond clinic-based services?
The announcement explains that HIV risk for adolescent girls and young women is heavily shaped by structural and social factors such as poverty, gender inequality, sexual violence, and barriers to education. Because of this, DREAMS emphasizes a layered, evidence-based package that reaches beyond the health sector.
15) What kinds of interventions are expected under DREAMS?
DREAMS programming is expected to combine biomedical, behavioral, and structural interventions, linking health services with community and social supports.
16) What are the main DREAMS objectives highlighted in the opportunity?
The opportunity highlights four main objectives: empowering girls and young women, mobilizing communities, strengthening families, and providing social protection.
17) What does "empowering girls and young women" mean in this context?
Based on the announcement, this objective centers on increasing girls agency and resilience as part of a broader prevention approach.
18) What does "mobilizing communities" mean in this context?
It refers to shifting harmful community norms and engaging communities in ways that reduce vulnerability and support safer environments for adolescent girls and young women.
19) What does "strengthening families" mean in this context?
It refers to improving family support systems that contribute to adolescent girls and young women being safer and less vulnerable to HIV risk.
20) What does "providing social protection" mean in this context?
It means connecting beneficiaries to services and supports that reduce economic and social vulnerability, which the announcement links to HIV risk.
21) What outcomes does the announcement connect to DREAMS programming?
The opportunity links DREAMS objectives to outcomes such as improved school enrollment, attendance, and completion at the secondary level, as well as reductions in violence and unintended pregnancy.
22) Where in South Africa will the supported DREAMS work be focused?
The work is focused on five priority districts: eThekwini, uMgungundlovu, and uMkhanyakude in KwaZulu-Natal, and the City of Johannesburg and Ekurhuleni in Gauteng.
23) How targeted is the geographic focus within those districts?
Across the five districts there are 31 sub-districts, and DREAMS concentrates efforts in 19 sub-districts identified as high burden and high transmission areas.
24) What does the targeting of high-burden sub-districts imply for implementation?
It signals that applicants are expected to plan for intensive, localized implementation in areas where incidence and transmission dynamics are most acute.
25) What prevention targets are mentioned for adolescent girls and young women (15-24)?
The FOA states DREAMS goals to reduce new HIV infections in this age group by 25 percent by the end of 2016 and by 40 percent by the end of 2017.
26) What do those targets suggest about the program design?
They imply a strong focus on measurable impact, rapid scale-up in priority sub-districts, and coordinated delivery of multiple interventions rather than isolated activities.
27) What does the announcement say about local capacity and sustainability?
A central intent is to build local capacity and sustainability so that services and protective factors remain in place over time, not only addressing immediate prevention needs.
28) Who is eligible to apply, based on the information provided?
The eligibility field is listed as "Others," and the narrative references Health Systems Trust. Based on the summary alone, CDC is seeking an eligible organization capable of coordinating and implementing a multi-sectoral, evidence-driven DREAMS package under a cooperative agreement structure.
29) Does the opportunity specify a required implementing partner?
The provided summary does not explicitly state a required implementing partner. It notes a reference to Health Systems Trust and indicates eligibility is categorized as "Others."
30) What does "multi-sectoral" implementation mean here?
In this announcement, it refers to working across health services and community/social support systems, addressing biomedical, behavioral, and structural drivers of HIV vulnerability.
31) When was the opportunity posted?
The opportunity was posted on January 8, 2016.
32) What was the application closing date?
The application closing date listed is March 8, 2016.
33) How does this timeline relate to DREAMS rollout?
The summary describes it as a time-bound call aligned to early DREAMS rollout timelines.
Browse more opportunities from the same category: Health
Next opportunity: Behavioral and Integrative Treatment Development Program (R34)
Previous opportunity: Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 1109SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 1109SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in the Republic of South Africa under PEPFAR Apply for CDC RFA GH11 1152SUPP16 Funding Number: CDC RFA GH11 1152SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in South Africa under PEPFAR Apply for CDC RFA GH11 1154SUPP16 Funding Number: CDC RFA GH11 1154SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| The USAID Global Health Development Innovation Accelerator Broad Agency Announcement (BAA) Addendum 03 Apply for BAA GLOBALHEALTH 2016 Funding Number: BAA GLOBALHEALTH 2016 Agency: USAID Category: Health Funding Amount: Case Dependent |
| Centers for Disease Control and Prevention Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis-TIPS) among Non-urban Young Persons Who Inject Drugs Apply for RFA PS 14 00403CONT16 Funding Number: RFA PS 14 00403CONT16 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| NIDCR Small Research Grants for Data Analysis and Statistical Methodology Applied to Genome-wide Data (R03) Apply for PAR 16 070 Funding Number: PAR 16 070 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Establishment of a Strategic Partnership to Strengthen the South African National AIDS Council (SANAC) under PEPFAR Apply for CDC RFA GH13 1338SUPP16 Funding Number: CDC RFA GH13 1338SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| South African University-Based Technical Assistance aimed at Improving the Quality of HIV/AIDS and Related Services in SA under PEPFAR Apply for CDC RFA GH15 1574SUPP16 Funding Number: CDC RFA GH15 1574SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Support for Health System Strengthening of Leadership, Governance and Quality Improvement in the Ministry of Health (MOH) in the Kingdom of Swaziland under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1584CONT16 Funding Number: CDC RFA GH15 1584CONT16 Agency: HHS-CDC Category: Health Funding Amount: $685,000 |
| Comprehensive Facility-Based Technical Assistance in the Context of Health Systems Strengthening in South Africa under PEPFAR Apply for CDC RFA GH12 1257SUPP16 Funding Number: CDC RFA GH12 1257SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Secretary’s Minority AIDS Initiative Funding to Increase HIV Prevention and Care Service Delivery among Health Centers Serving High HIV Prevalence Jurisdictions Apply for CDC RFA PS14 141003CONT16 Funding Number: CDC RFA PS14 141003CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Sodium Reduction in Communities Apply for CDC RFA DP16 1607 Funding Number: CDC RFA DP16 1607 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $500,000 |
| Well Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) Program Apply for CDC RFA DP13 130204CONT16 Funding Number: CDC RFA DP13 130204CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Building Ryan White HIV/AIDS Program Recipient Capacity to Engage People Living with HIV in Health Care Access Apply for HRSA 16 081 Funding Number: HRSA 16 081 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Part C Capacity Development Program Apply for HRSA 16 088 Funding Number: HRSA 16 088 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| State Public Health Approaches to Improving Arthritis Outcomes Apply for CDC RFA DP12 121005CONT16 Funding Number: CDC RFA DP12 121005CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| International Research Ethics Education and Curriculum Development Award (R25) Apply for PAR 16 081 Funding Number: PAR 16 081 Agency: HHS-NIH11 Category: Health Funding Amount: $230,000 |
| Cohort Study to Assess Population Impact of Current and Evolving Chronic Viral Hepatitis Treatment Apply for RFA PS 16 002 Funding Number: RFA PS 16 002 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $500,000 |
| NIDCD National Human Ear Tissue Laboratory Resource for Hearing and Balance Research (U24) Apply for RFA DC 17 001 Funding Number: RFA DC 17 001 Agency: HHS-NIH11 Category: Health Funding Amount: $475,000 |
| 2016 Cooperative Agreements to Benefit Homeless Individuals (Short Title: CABHI) Apply for SM 16 007 Funding Number: SM 16 007 Agency: HHS-SAMHS Category: Health Funding Amount: $1,500,000 |
| State Public Health Actions to Prevent and Control Diabetes, Heart Disease, Obesity and Associated Risk Factors and Promote School Health Apply for CDC RFA DP13 130504CONT16 Funding Number: CDC RFA DP13 130504CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 1109SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.